AZENTA INC (AZTA) Fundamental Analysis & Valuation

NASDAQ:AZTA • US1143401024

Current stock price

25.11 USD
-1.35 (-5.1%)
At close:
25.11 USD
0 (0%)
After Hours:

This AZTA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. AZTA Profitability Analysis

1.1 Basic Checks

  • In the past year AZTA was profitable.
  • In the past year AZTA had a positive cash flow from operations.
  • In multiple years AZTA reported negative net income over the last 5 years.
  • AZTA had a positive operating cash flow in 4 of the past 5 years.
AZTA Yearly Net Income VS EBIT VS OCF VS FCFAZTA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B 1.5B 2B

1.2 Ratios

  • With a Return On Assets value of -2.79%, AZTA perfoms like the industry average, outperforming 58.93% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of -3.37%, AZTA is in the better half of the industry, outperforming 62.50% of the companies in the same industry.
Industry RankSector Rank
ROA -2.79%
ROE -3.37%
ROIC N/A
ROA(3y)-3.69%
ROA(5y)10.48%
ROE(3y)-4.38%
ROE(5y)11.73%
ROIC(3y)N/A
ROIC(5y)N/A
AZTA Yearly ROA, ROE, ROICAZTA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

1.3 Margins

  • The Gross Margin of AZTA (44.59%) is comparable to the rest of the industry.
  • AZTA's Gross Margin has been stable in the last couple of years.
  • The Profit Margin and Operating Margin are not available for AZTA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 44.59%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.36%
GM growth 5Y0.54%
AZTA Yearly Profit, Operating, Gross MarginsAZTA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 200 300

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. AZTA Health Analysis

2.1 Basic Checks

  • AZTA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • AZTA has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, AZTA has less shares outstanding
  • The debt/assets ratio for AZTA has been reduced compared to a year ago.
AZTA Yearly Shares OutstandingAZTA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
AZTA Yearly Total Debt VS Total AssetsAZTA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

  • AZTA has an Altman-Z score of 3.54. This indicates that AZTA is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of AZTA (3.54) is better than 73.21% of its industry peers.
  • AZTA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3.54
ROIC/WACCN/A
WACC11.1%
AZTA Yearly LT Debt VS Equity VS FCFAZTA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

2.3 Liquidity

  • A Current Ratio of 2.92 indicates that AZTA has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 2.92, AZTA is in line with its industry, outperforming 55.36% of the companies in the same industry.
  • A Quick Ratio of 2.61 indicates that AZTA has no problem at all paying its short term obligations.
  • AZTA has a Quick ratio (2.61) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 2.92
Quick Ratio 2.61
AZTA Yearly Current Assets VS Current LiabilitesAZTA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. AZTA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 14.89% over the past year.
  • AZTA shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -16.04% yearly.
  • The Revenue has decreased by -8.40% in the past year.
  • AZTA shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.86% yearly.
EPS 1Y (TTM)14.89%
EPS 3Y0.64%
EPS 5Y-16.04%
EPS Q2Q%12.5%
Revenue 1Y (TTM)-8.4%
Revenue growth 3Y2.25%
Revenue growth 5Y8.86%
Sales Q2Q%0.77%

3.2 Future

  • The Earnings Per Share is expected to grow by 27.49% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, AZTA will show a small growth in Revenue. The Revenue will grow by 5.37% on average per year.
EPS Next Y50.47%
EPS Next 2Y43.51%
EPS Next 3Y35.52%
EPS Next 5Y27.49%
Revenue Next Year5.38%
Revenue Next 2Y5.68%
Revenue Next 3Y5.78%
Revenue Next 5Y5.37%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AZTA Yearly Revenue VS EstimatesAZTA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
AZTA Yearly EPS VS EstimatesAZTA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2 2.5

More info and screens

Find the best growth stocksShow best growing peers

5

4. AZTA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 46.50, which means the current valuation is very expensive for AZTA.
  • AZTA's Price/Earnings ratio is a bit cheaper when compared to the industry. AZTA is cheaper than 62.50% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of AZTA to the average of the S&P500 Index (27.47), we can say AZTA is valued expensively.
  • The Price/Forward Earnings ratio is 23.00, which indicates a rather expensive current valuation of AZTA.
  • Based on the Price/Forward Earnings ratio, AZTA is valued a bit cheaper than 75.00% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of AZTA to the average of the S&P500 Index (22.62), we can say AZTA is valued inline with the index average.
Industry RankSector Rank
PE 46.5
Fwd PE 23
AZTA Price Earnings VS Forward Price EarningsAZTA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • 76.79% of the companies in the same industry are more expensive than AZTA, based on the Enterprise Value to EBITDA ratio.
  • AZTA's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. AZTA is cheaper than 64.29% of the companies in the same industry.
Industry RankSector Rank
P/FCF 37.39
EV/EBITDA 18.44
AZTA Per share dataAZTA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as AZTA's earnings are expected to grow with 35.52% in the coming years.
PEG (NY)0.92
PEG (5Y)N/A
EPS Next 2Y43.51%
EPS Next 3Y35.52%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. AZTA Dividend Analysis

5.1 Amount

  • AZTA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AZTA Fundamentals: All Metrics, Ratios and Statistics

AZENTA INC

NASDAQ:AZTA (4/23/2026, 8:00:01 PM)

After market: 25.11 0 (0%)

25.11

-1.35 (-5.1%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-04
Earnings (Next)05-11
Inst Owners116.07%
Inst Owner Change-0.24%
Ins Owners0.69%
Ins Owner Change12.39%
Market Cap1.16B
Revenue(TTM)594.95M
Net Income(TTM)-57.85M
Analysts77.14
Price Target36.28 (44.48%)
Short Float %11.64%
Short Ratio5.43
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-13.65%
Min EPS beat(2)-35.95%
Max EPS beat(2)8.65%
EPS beat(4)2
Avg EPS beat(4)-5.26%
Min EPS beat(4)-35.95%
Max EPS beat(4)36.22%
EPS beat(8)6
Avg EPS beat(8)46.66%
EPS beat(12)9
Avg EPS beat(12)140.12%
EPS beat(16)13
Avg EPS beat(16)118.13%
Revenue beat(2)0
Avg Revenue beat(2)-0.51%
Min Revenue beat(2)-0.98%
Max Revenue beat(2)-0.05%
Revenue beat(4)0
Avg Revenue beat(4)-1.7%
Min Revenue beat(4)-5.56%
Max Revenue beat(4)-0.05%
Revenue beat(8)1
Avg Revenue beat(8)-1.26%
Revenue beat(12)4
Avg Revenue beat(12)-0.9%
Revenue beat(16)6
Avg Revenue beat(16)-1.08%
PT rev (1m)-5.68%
PT rev (3m)-9.78%
EPS NQ rev (1m)-4.14%
EPS NQ rev (3m)-26.84%
EPS NY rev (1m)-0.71%
EPS NY rev (3m)-0.16%
Revenue NQ rev (1m)0.03%
Revenue NQ rev (3m)-0.36%
Revenue NY rev (1m)0.44%
Revenue NY rev (3m)0.76%
Valuation
Industry RankSector Rank
PE 46.5
Fwd PE 23
P/S 1.94
P/FCF 37.39
P/OCF 18.53
P/B 0.67
P/tB 1.26
EV/EBITDA 18.44
EPS(TTM)0.54
EY2.15%
EPS(NY)1.09
Fwd EY4.35%
FCF(TTM)0.67
FCFY2.67%
OCF(TTM)1.35
OCFY5.4%
SpS12.92
BVpS37.23
TBVpS19.88
PEG (NY)0.92
PEG (5Y)N/A
Graham Number21.2685 (-15.3%)
Profitability
Industry RankSector Rank
ROA -2.79%
ROE -3.37%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 44.59%
FCFM 5.2%
ROA(3y)-3.69%
ROA(5y)10.48%
ROE(3y)-4.38%
ROE(5y)11.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.36%
GM growth 5Y0.54%
F-Score5
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 55.45%
Cap/Sales 5.29%
Interest Coverage N/A
Cash Conversion 156.34%
Profit Quality N/A
Current Ratio 2.92
Quick Ratio 2.61
Altman-Z 3.54
F-Score5
WACC11.1%
ROIC/WACCN/A
Cap/Depr(3y)47.53%
Cap/Depr(5y)73.52%
Cap/Sales(3y)6.46%
Cap/Sales(5y)8.72%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.89%
EPS 3Y0.64%
EPS 5Y-16.04%
EPS Q2Q%12.5%
EPS Next Y50.47%
EPS Next 2Y43.51%
EPS Next 3Y35.52%
EPS Next 5Y27.49%
Revenue 1Y (TTM)-8.4%
Revenue growth 3Y2.25%
Revenue growth 5Y8.86%
Sales Q2Q%0.77%
Revenue Next Year5.38%
Revenue Next 2Y5.68%
Revenue Next 3Y5.78%
Revenue Next 5Y5.37%
EBIT growth 1Y71.09%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year493.88%
EBIT Next 3Y107.95%
EBIT Next 5YN/A
FCF growth 1Y-4.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-12.01%
OCF growth 3YN/A
OCF growth 5Y13.75%

AZENTA INC / AZTA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for AZENTA INC?

ChartMill assigns a fundamental rating of 5 / 10 to AZTA.


What is the valuation status for AZTA stock?

ChartMill assigns a valuation rating of 5 / 10 to AZENTA INC (AZTA). This can be considered as Fairly Valued.


Can you provide the profitability details for AZENTA INC?

AZENTA INC (AZTA) has a profitability rating of 3 / 10.


How financially healthy is AZENTA INC?

The financial health rating of AZENTA INC (AZTA) is 8 / 10.


What is the expected EPS growth for AZENTA INC (AZTA) stock?

The Earnings per Share (EPS) of AZENTA INC (AZTA) is expected to grow by 50.47% in the next year.